BAUSCH HEALTH COS INC 5.75 percent 15Aug2027 is a Senior Secured Note issued by the corporate entity on the 22nd of February 2019. Bausch is trading at 64.00 as of the 22nd of December 2024, a 26.84 percent decrease since the beginning of the trading day. The bond's open price was 87.48. Bausch has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of November 2024 and ending today, the 22nd of December 2024. Click here to learn more.
Bausch Health Companies Inc. is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. More on Bausch Health Companies
Our tools can tell you how much better you can do entering a position in Bausch without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bausch financial ratios help investors to determine whether Bausch Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bausch with respect to the benefits of owning Bausch security.